Academic literature on the topic 'Pharmaceutical care'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharmaceutical care.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Pharmaceutical care"
Chrisp, Paul. "Pharmaceutical care." Inpharma Weekly &NA;, no. 894 (July 1993): 5–6. http://dx.doi.org/10.2165/00128413-199308940-00008.
Full textKIELGAST, PETER J. "Pharmaceutical care." International Journal of Pharmacy Practice 2, no. 3 (November 1993): 125–26. http://dx.doi.org/10.1111/j.2042-7174.1993.tb00742.x.
Full textHepler, Charles D. "Pharmaceutical care." Pharmacy World and Science 18, no. 6 (1996): 233–35. http://dx.doi.org/10.1007/bf00735965.
Full textHopefl, Alan W. "Costs of Pharmaceutical Care: Can the Profession do Anything?" Annals of Pharmacotherapy 26, no. 12 (December 1992): 1585–88. http://dx.doi.org/10.1177/106002809202601219.
Full textAllwood, M. C., C. L. Ronchera-Oms, T. Sizer, B. McElroy, and G. Hardy. "From pharmaceutics to pharmaceutical care in nutritional support." Clinical Nutrition 14, no. 1 (February 1995): 1–3. http://dx.doi.org/10.1016/s0261-5614(06)80002-6.
Full textBomfim, José Henrique Gialongo Gonçales. "Pharmaceutical Care in Sports." Pharmacy 8, no. 4 (November 16, 2020): 218. http://dx.doi.org/10.3390/pharmacy8040218.
Full textLaven, David L., and William B. Hladik. "Pharmaceutical Care and Diagnostic Pharmaceuticals: Patient Care Avenues Not to Be Overlooked." Journal of Pharmacy Practice 7, no. 3 (June 1994): 79–83. http://dx.doi.org/10.1177/089719009400700302.
Full textManasse, Henri R. "The Care in Pharmaceutical Care." Journal of Pharmacy Teaching 3, no. 3 (1992): 39–52. http://dx.doi.org/10.1300/j060v03n03_06.
Full textHill, Peter. "Pharmaceutical care R.I.P?" International Journal of Pharmacy Practice 20, no. 1 (January 11, 2012): 2–3. http://dx.doi.org/10.1111/j.2042-7174.2011.00184.x.
Full textMorley, P. C. "Pharmaceutical care: desiderata." Journal of Clinical Pharmacy and Therapeutics 18, no. 3 (June 1993): 143–46. http://dx.doi.org/10.1111/j.1365-2710.1993.tb00604.x.
Full textDissertations / Theses on the topic "Pharmaceutical care"
Clifford, Rhonda Marise. "Pharmaceutical care in diabetes mellitus." Curtin University of Technology, School of Pharmacy, 2004. http://espace.library.curtin.edu.au:80/R/?func=dbin-jump-full&object_id=14951.
Full textDemographic parameters, including ethnicity and treatment details, were reviewed at study entry for the full FDS cohort and then over time for a subset of patients that returned for four subsequent annual assessments. Insulin use was more common in patients of Southern European origin compared with the Anglo-Celt group irrespective of the level of glycaemia, at baseline. This difference persisted during subsequent follow-up but was not associated with improved glycaemic control. These findings demonstrated that there are important ethnic differences in the management of patients with type 2 diabetes mellitus. The pilot pharmaceutical care program was carried out in high-risk diabetes mellitus patients attending a hospital outpatient clinic. The patients had poor glycaemic control, dyslipidaemia, hypertension and/or were on three or more prescription medications. In the pharmaceutical care arm, a clinical pharmacist reviewed and monitored all aspects of the patients' drug therapy in collaboration with other health care professionals at six weekly intervals for six months. The control patients received usual outpatient care. Seventy-three patients were recruited into the study, of whom 48 (66%) were randomised to receive pharmaceutical care. One in six patients was taking complementary medicines. The pharmaceutical care program provided patients with important medication information that resulted in changes to drug therapy. However, the six-month program did not lead to an improvement in glycaemic control. The next phase of the study adapted the pilot hospital-based pharmaceutical care program to a community-based setting.
Two hundred and two type 2 diabetes mellitus FDS patients were recruited, of whom 101 (50%) were randomised to the pharmaceutical care program, and all were followed for 12-months. There were significant reductions in risk factors associated with coronary heart disease in the case but not the control group over time, specifically glycaemic control, lipid levels, and blood pressure. Glycosylated haemoglobin fell from 7.5% to 7.0% (P<0.0001), total cholesterol fell from 5 mmol/L to 4.6 mmol/L (P<0.0001), systolic blood pressure fell from 158 mmHg to 143 mmHg (P<0.0001) and diastolic blood pressure fell from 77mmHg to 71mmHg (P<0.0001). Multiple linear regression analysis confirmed that pharmaceutical care program involvement was an independent predictor of benefit after adjustment for key variables. The 10-year coronary heart disease risk for patients without a previous coronary event was reduced by 4.6% over the 12-month study period in the pharmaceutical care group (P<0.0001), while there was no change in the controls (P=0.23). This phase of the study showed that medium-term individualised pharmaceutical care reduced vascular risk factors in a community-based cohort of patients with diabetes and that provision of a multifactorial intervention can improve health outcomes in type 2 diabetes mellitus. As part of the pharmaceutical care program, a high level of complementary medicine use was found. As a result, a study of complementary medicine use was undertaken in 351 patients from the FDS. A convenience sample of FDS patients was interviewed regarding their use of complementary medicines. A literature search was conducted to assess the potential impact of these medicines on diabetes, concomitant medications or diabetes-related co-morbidities.
Eighty-three of 351 (23.6%) patients with diabetes had consumed at least one complementary medicine in the previous year and 42% (77/183) of the products potentially necessitated additional patient monitoring or could be considered potentially inappropriate for a diabetic patient. The data indicated the need for patient disclosure of complementary medicine use and adequate monitoring for complementary medicine-related adverse events, as part of the pharmaceutical care process. The pharmaceutical care model was established to provide a framework by which drug use could be improved to enhance patients' clinical and health-related quality of life outcomes. For the present study, a straightforward pharmaceutical care program was adapted from a hospital setting to a community setting, where the principal requirement was a clinical pharmacist who had completed a self-directed diabetes-training program. In this context, clinically relevant parameters improved over the course of the study period. Pharmaceutical care programs such as this can begin the process of translating the findings of large and expensive clinical trials into standard clinical practice.
Clifford, Rhonda. "Pharmaceutical care in diabetes mellitus." Thesis, Curtin University, 2004. http://hdl.handle.net/20.500.11937/1907.
Full textAl, Mazroui Nadia. "Pharmaceutical care of type 2 diabetic patients." Thesis, Queen's University Belfast, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.431401.
Full textBronkhorst, Elmien. "An Assessment of the need of pharmaceutical services in the intensive care unit and high care unit of Steve Biko Academic hospital." Thesis, University of Limpopo (Medunsa Campus), 2012. http://hdl.handle.net/10386/1081.
Full textThe role of the pharmacist has evolved over the last two decades beyond the traditional functions of dispensing and stock control. The focus has shifted toward patient-oriented functions, in which the pharmacist assumes responsibility for the patient’s drug- and healthcare needs as well as the outcome of treatment. The aim of this research was to assess the need for pharmaceutical care to the Surgical Intensive Care Unit of Steve Biko Hospital. The surgical and trauma ICU is a 12 bed unit to which the researcher rendered pharmaceutical care over an eight week period, from 14 February to 26 March 2011. Interventions to assess drug therapy and achieve definite outcomes to improve patients’ quality of life were documented for 51 study patients according to the system developed by the American Society of Health-System Pharmacists (1992). Of the 51 patients, 35 were male and 16 were female. The age of the patients ranged from 12 years to 86 years, with most patients admitted to the unit in the age groups 21 to 30 years, and 51 to 60 years. The patients’ estimated weights ranged from 40kg to 120kg with older patients, from age 41 upwards, weighing more. The average stay in the unit was 8.7 days, with the minimum stay for one patient being only one day, and the maximum stay for one patient was 26 days. In the study, the HIV status of only 13 of the 51 patients was tested. Of the 13 patients, six were HIV positive, while seven tested negative. All the patients admitted to the unit were not tested for HIV, because they were not admitted to the unit for HIV-related causes, and test results would not have had an effect on their outcome. Diagnoses encountered most frequently in the unit were trauma (21 patients), skeletal involvement or fractures (16 patients), infections or sepsis (15 patients) and gastro-intestinal bleeds (14 patients). In most cases more than one diagnosis applied to the same patient, since patients admitted with trauma also had skeletal or gastro-intestinal involvement. An Assessment of the need of Pharmaceutical Services in the Intensive Care Unit and High Care Unit of Steve Biko Academic Hospital viii The medications prescribed most frequently were enoxaparin (49 patients), sucralfate (41 patients) and multivitamin syrup (47 patients); in accordance with the standard ward protocol for prophylactic regimens. The drug class most often used was the anti-infectiveshaving124 items prescribed during the study period. Of these, the broad spectrum antibiotics were used most frequently, e.g. piperacillin/tazobactam (22 patients), meropenem (11 patients) and imipenem (11 patients). An average of 12 medications was prescribed for each patient in the ward. A total of 181 interventions were suggested for the 51 patients during the study period, of which 127 (70%) were accepted and implemented by the medical and nursing staff. The average number of interventions per patient ranged from 0 to 13 with a median of 3.5 interventions per patient. The four most frequent problem types were untreated medical conditions (15.5%), length or course of therapy inappropriate (13.8%), investigations indicated or outstanding (12.2%) and prescribed doses and dosing frequency appropriate (11%). Interventions were also made regularly to address system errors or non-compliance and factors hindering achievement of therapeutic effect. The perceived need for pharmaceutical care by healthcare professionals in the SICU was measured by questionnaires before and after the study period. The feedback by staff regarding the pharmacist working in the ward was very positive. They appreciated the researchers input on ward rounds, as well as assistance with problems encountered with the pharmacy. Of the total time spent in the ward, the researcher spent 28% of her time on patient evaluation. Ward rounds also took up a great deal of time (21.7%), since ward rounds were done with different members of the multidisciplinary team. Most interventions were suggested during ward rounds. The costs saved during the study period were enough to justify the appointment of a pharmacist to the ward on a permanent basis, albeit for limited hours daily. The researcher designed an antibiotic protocol for the unit. The protocol was designed according to international standards, and after discussion with the microbiologists, adapted for use in the specific unit. An Assessment of the need of Pharmaceutical Services in the Intensive Care Unit and High Care Unit of Steve Biko Academic Hospital ix In conclusion, the study results have demonstrated that a pharmacist’s contribution to patient care at ward level in a surgical ICU resulted in clinical outcomes that improved the patient’s quality of life. Drug-related problems were identified and addressed. Medical staff in the S-ICU accepted the pharmacist’s interventions and even welcomed her contribution to other ward functions, for instance managing medication and providing education. Pharmaceutical care should be rendered on a permanent basis to the Surgical ICU and the pharmacist should increasingly become a key part of the multidisciplinary team, taking responsibility for patients’ medication needs.
Varma, Sumanthra. "Pharmaceutical care of elderly congestive heart failure patients." Thesis, Queen's University Belfast, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.388199.
Full textSturgess, Ian K. "Pharmaceutical care provision to community dwelling elderly patients." Thesis, Queen's University Belfast, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268313.
Full textSadik, A. S. "Pharmaceutical care of patients with congestive heart failure." Thesis, Queen's University Belfast, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269178.
Full textScanlan, Justine Claire. "Pharmaceutical care for cancer patients : a multidisciplinary approach." Thesis, University College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.289814.
Full textStern, Philip. "Patterns of pharmaceutical prescribing." Thesis, London Business School (University of London), 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309363.
Full textGlynn, Caroline. "Aspects of pharmaceutical care provision by the community pharmacist." Thesis, Queen's University Belfast, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337033.
Full textBooks on the topic "Pharmaceutical care"
Penna, Richard P., and Calvin H. Knowlton. Pharmaceutical care. 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists, 2003.
Find full textJ, Cipolle Robert, Morley Peter C, and Cipolle Robert J, eds. Pharmaceutical care practice. 3rd ed. New York: McGraw-Hill, 2012.
Find full textM, Strand Linda, and Morley Peter C, eds. Pharmaceutical care practice. New York: McGraw-Hill, Health Professions Division, 1998.
Find full textInterpersonal communication in pharmaceutical care. New York: Pharmaceutical Products Press, 1994.
Find full textGalt, Kimberly A. Clinical skills program: Advancing pharmaceutical care. Bethesda, MD: American Society of Hospital Pharmacists, 1994.
Find full textN, Tindall William, and Millonig Marsha K, eds. Pharmaceutical care: Insights from community pharmacists. Boca Raton: CRC Press, 2003.
Find full textP, Rovers John, ed. A practical guide to pharmaceutical care. Washington, D.C: American Pharmaceutical Association, 1998.
Find full textP, Rovers John, ed. A practical guide to pharmaceutical care. 2nd ed. Washington, D.C: American Pharmaceutical Association, 2003.
Find full textR, Moore Steven, ed. Geriopharmacotherapy in home health care: New frontiers in pharmaceutical care. New York: Haworth Press, 1993.
Find full textC, Smith Mickey, and Wertheimer Albert I, eds. Social and behavioral aspects of pharmaceutical care. New York: Pharmaceutical Products Press, 1996.
Find full textBook chapters on the topic "Pharmaceutical care"
Westerlund, Tommy. "Documenting Pharmaceutical Care." In The Pharmacist Guide to Implementing Pharmaceutical Care, 89–94. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92576-9_8.
Full textKhatri, Naresh. "Pharmaceutical Companies." In Crony Capitalism in US Health Care, 38–44. New York: Routledge, 2021. http://dx.doi.org/10.4324/9781003112204-7.
Full textAlves da Costa, Filipa. "Pharmaceutical Care in Europe." In The Pharmacist Guide to Implementing Pharmaceutical Care, 159–71. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92576-9_14.
Full textLee, Shaun Wen Huey, and J. Simon Bell. "Pharmaceutical Care in Asia." In The Pharmacist Guide to Implementing Pharmaceutical Care, 191–97. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92576-9_17.
Full textMoles, Rebekah, and Stephen Carter. "Pharmaceutical Care in Pediatrics." In The Pharmacist Guide to Implementing Pharmaceutical Care, 381–95. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92576-9_31.
Full textAlves da Costa, Filipa, and Kurt E. Hersberger. "Paying for Pharmaceutical Care." In The Pharmacist Guide to Implementing Pharmaceutical Care, 461–66. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92576-9_38.
Full textMarinkovic, Valentina, Marina Odalovic, Ivana Tadic, Dusanka Krajnovic, Irina Mandic, and Heather L. Rogers. "Person-Centred Care Interventions in Pharmaceutical Care." In Intelligent Systems for Sustainable Person-Centered Healthcare, 53–68. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-79353-1_4.
Full textAbbott, Thomas A. "Regulating Pharmaceutical Prices." In Health Care Policy and Regulation, 105–41. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-2219-5_7.
Full textNahler, Gerhard. "health care expenditure." In Dictionary of Pharmaceutical Medicine, 85. Vienna: Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_634.
Full textNahler, Gerhard. "health care services." In Dictionary of Pharmaceutical Medicine, 85. Vienna: Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_635.
Full textConference papers on the topic "Pharmaceutical care"
Nascimento, A., S. R. Castilho, R. M. V. R. Almeida, and A. F. C. Infantosi. "Evaluating pharmaceutical assistance activities in Brazilian hospitals." In 2011 Pan American Health Care Exchanges (PAHCE 2011). IEEE, 2011. http://dx.doi.org/10.1109/pahce.2011.5871863.
Full textCosta, Wanderson, José Rafael Nascimento, Elisa Menendez, Marcos Dósea, Leila Silva, Monique Jabbur, Ana Patrícia Lima, and Divaldo Lyra Junior. "A system to help the teaching of pharmaceutical care." In the 6th Euro American Conference. New York, New York, USA: ACM Press, 2012. http://dx.doi.org/10.1145/2261605.2261620.
Full textArroyo-Jiménez, María Del Mar, Sara Mínguez, Jose Antonio Carbajal, Lucía Castro-Vázquez, Joaquïn González-Fuentes, and Gema Blázquez-Abellán. "II WORKSHOP OF PHARMACEUTICAL CARE OF PARKINSON'S DISEASE PATIENTS." In 11th annual International Conference of Education, Research and Innovation. IATED, 2018. http://dx.doi.org/10.21125/iceri.2018.1916.
Full textFarida, Yeni, Katarina Puspita, and Zahra Yusvida. "Empirical Antibiotics Study on Pneumonia in Intensive Care Unit." In 1st Muhammadiyah International Conference on Health and Pharmaceutical Development. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008239200480053.
Full textQuirós, V. Saavedra, R. Capilla Pueyo, I. Roch Hamelin, A. Medina Carrizo, MA Gómez Mateos, and A. Sánchez Guerrero. "4CPS-255 Expanding the process of pharmaceutical care to the institutionalised patient care unit." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.345.
Full textGruenwald, G., and T. Lee. "164. Glutaraldehyde Exposures after Disinfectant Fogging in Pharmaceutical Aseptic Rooms: Evaluation and Control." In AIHce 1996 - Health Care Industries Papers. AIHA, 1999. http://dx.doi.org/10.3320/1.2764825.
Full textJ., Camellia, Pramestutie H. R., and Hariadini A. L. ""Diarrhea Care Program" as Effective Pediatric Diarrhea Counseling Tool for Pharmacy Practice." In Annual International Conference on Pharmacology and Pharmaceutical Sciences. Global Science & Technology Forum (GSTF), 2014. http://dx.doi.org/10.5176/2345-783x_pharma14.27.
Full textHirano, Luciano Roberto, Silvio Bortoleto, Claudia Seiko Yokoyama, and Hugo Bulegon. "An information system for drug interactions: pharmaceutical care and prescription." In 2009 World Congress on Nature & Biologically Inspired Computing (NaBIC 2009). IEEE, 2009. http://dx.doi.org/10.1109/nabic.2009.5393548.
Full textMorera, D. Briegas, C. Bonilla Galán, C. Meneses Mangas, E. García Lobato, J. Pardal, LM Bravo García-Cuevas, S. Martín Clavo, R. Medina Comas, and JF Rangel Mayoral. "DI-001 Making pharmaceutical care easy by designing interactive software." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.248.
Full textRedondo Galán, C., MD Rivas Rodríguez, D. González Vaquero, M. Ferris Villanueva, and JF Rangel Mayoral. "4CPS-373 Pharmaceutical care in hospitalisation units: analysis of interventions." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.205.
Full textReports on the topic "Pharmaceutical care"
Zhong, Lirong, Alexandre V. Mitroshkov, and Tyler J. Gilmore. Analysis of Pharmaceutical and Personal Care Compounds in Wastewater Sludge and Aqueous Samples using GC-MS/MS. Office of Scientific and Technical Information (OSTI), March 2016. http://dx.doi.org/10.2172/1242343.
Full textMitroshkov, Alexandre V., Lirong Zhong, and Linda M. P. Thomas. Analysis of Perfluorinated, Pharmaceutical, Personal Care Compounds and Heavy Metals in Waste Water Sludge using GC-MS/MS and Multicollector ICP-MS. Office of Scientific and Technical Information (OSTI), January 2019. http://dx.doi.org/10.2172/1494304.
Full textLucarelli, Claudio, Sean Nicholson, and Minjae Song. Bundling Among Rivals: A Case of Pharmaceutical Cocktails. Cambridge, MA: National Bureau of Economic Research, August 2010. http://dx.doi.org/10.3386/w16321.
Full textHuber, Sandra, Mikael Remberger, Arntraut Goetsch, Kirsten Davanger, Lennart Kaj, Dorte Herzke, Martin Schlabach, et al. Pharmaceuticals and additives in personal care products as environmental pollutants. Nordic Council of Ministers, August 2013. http://dx.doi.org/10.6027/tn2013-541.
Full textChan, Leong. Developing a Strategic Policy Choice Framework for Technological Innovation: Case of Chinese Pharmaceuticals. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.1041.
Full textPeters, Joseph. Pharmaceutical Contaminants as Stressors on Rocky Intertidal and Estuarine Organisms: a Case Study of Fluoxetine. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.2725.
Full textFeliciano, Zadia, and Meng-Ting Chen. Intangible Assets, Corporate Taxes and the Relocation of Pharmaceutical Establishments: The case of Puerto Rico. Cambridge, MA: National Bureau of Economic Research, July 2021. http://dx.doi.org/10.3386/w29107.
Full textChaudhuri, Shubham, Pinelopi Goldberg, and Panle Jia. Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India. Cambridge, MA: National Bureau of Economic Research, December 2003. http://dx.doi.org/10.3386/w10159.
Full textHajarizadeh, Behzad, Jennifer MacLachlan, Benjamin Cowie, and Gregory J. Dore. Population-level interventions to improve the health outcomes of people living with hepatitis B: an Evidence Check brokered by the Sax Institute for the NSW Ministry of Health, 2022. The Sax Institute, August 2022. http://dx.doi.org/10.57022/pxwj3682.
Full textPandey, A., N. Bhattarai, B. ,. Adhikary, B. Karky, C. P. Pokhrel, and A. Pathak. Baseline Study of Endocrine-Disrupting Compounds and Pharmaceuticals and Personal Care Products in Waterways Surrounding Chitwan National Park, Nepal; Field Report 2018. Kathmandu, Nepal: International Centre for Integrated Mountain Development (ICIMOD), 2018. http://dx.doi.org/10.53055/icimod.713.
Full text